The role of mannose-binding lectin in pneumococcal infection

European Respiratory Journal

Volumn 41, Issue 1, 2013, Pages 131-139

  García Laorden, M Isabel ^a   Rodríguez De Castro, Felipe ^a,b   Solé Violán, Jordi ^a   Payeras, Antoni ^c   Briones, M Luisa ^d   Borderías, Luis ^e   Aspa, Javier ^f   Blanquer, José ^d   Rajas, Olga ^f   Marcos Ramos, J Alberto ^g   Herrera Ramos, Estefanía ^a   García Bello, Miguel A ^a   Noda, Judith ^a   Ferrer, José M ^a   Rello, Jordi ^h   Rodríguez Gallego, Carlos ^a,b  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HOSPITAL SAN JORGE   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL GENERAL DE LANZAROTE   (Spain)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Mannose binding lectin; Pneumococcus; Polymorphism; Sepsis; Streptococcus pneumoniae; Surfactant protein

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANNOSE BINDING LECTIN GENE; MISSENSE MUTATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SFTPA1 GENE; SFTPA2 GENE; SFTPD GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SURFACTANT PROTEIN GENE;

COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES;

EID: 84872170532     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00174111     Document Type: Article

References (33)

1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72.
2. Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006; 68: 193-209.
3. García-Laorden MI, Manzanedo A, Figuerola A, et al. Mannose-binding lectin polymorphisms in a Canary Islands (Spain) population. Genes Immun 2001; 2: 292-294.
4. Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120: 776-794.
5. Verdu P, Barreiro LB, Patin E, et al. Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet 2006; 15: 2650-2658.
6. Eisen DP. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun 2010; 2: 114-122.
7. Roy S, Knox K, Segal S, et al. Oxford Pneumoccocal Surveillance Group. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 2002; 359: 1569-1573.
8. Moens L, Van Hoeyveld E, Peetermans WE, et al. Mannose-binding lectin genotype and invasive pneumococcal infection. Hum Immunol 2006; 67: 605-611.
9. Kronborg G, Weis N, Madsen HO, et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis 2002; 185: 1517-1520.
10. Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693.
11. Brown JS, Hussell T, Gilliland SM, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 2002; 99: 16969-16974.
12. Brouwer N, Dolman KM, van Houdt M, et al. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J Immunol 2008; 180: 4124-4132.
13. Boldt AB, Messias-Reason IJ, Meyer D, et al. Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet 2010; 11: 38.
14. Garcia-Laorden MI, Sole-Violan J, Rodriguez de Castro F, et al. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol 2008; 122: 368-374.
15. Haczku A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol 2008; 122: 861-879.
16. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5: 58-68.
17. García-Laorden MI, Rodríguez de Castro F, Solé-Violán J, et al. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study. Crit Care 2011; 15: R57.
18. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 1998; 18: 353-362.
19. Perez-Castellano M, Peñaranda M, Payeras A, et al. Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol 2006; 145: 228-234.
20. García-Laorden MI, Rúa-Figueroa I, Pérez-Aciego P, et al. Mannose binding lectin polymorphisms as a disease-modulating factor in women with systemic lupus erythematosus from Canary Islands, Spain. J Rheumatol 2003; 30: 740-746.
21. DiAngelo S, Lin Z, Wang G, et al. Novel., non-radioactive, simple and multiplex PCR-Crflp methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999; 15: 269-281.
22. Endeman H, Herpers BL, de Jong BA, et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest 2008; 134: 1135-1140.
23. Brouwer MC, de Gans J, Heckenberg SG, et al. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 31-44.
24. Garcia-Laorden MI, Pena MJ, Caminero JA, et al. Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population. Mol Immunol 2006; 43: 2143-2150.
25. Eisen DP, Dean MM, Boermeester MA, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008; 47: 510-516.
26. Swierzko AS, Szala A, Cedzynski M, et al. Mannan-binding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates. Hum Immunol 2009; 70: 68-72.
27. Vallès X, Roca A, Lozano F, et al. Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur Respir J 2010; 36: 856-863.
28. Chalmers JD, Fleming GB, Hill AT, et al. Impact of mannosebinding lectin insufficiency on the course of cystic fibrosis: a review and meta-analysis. Glycobiology 2011; 21: 271-282.
29. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374: 893-902.
30. Denholm JT, McBryde ES, Eisen DP. Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol 2010; 162: 84-90.
31. Stuart LM, Takahashi K, Shi L, et al. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 2005; 174: 3220-3226.
32. Nadesalingam J, Dodds AW, Reid KBM, et al. Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J Immunol 2005; 175: 1785-1794.
33. Bang P, Laursen I, Thornberg K, et al. The pharmacokinetic profile of plasma-derived mannan-binding lectin in healthy adult volunteers and patients with Staphylococcus aureus septicaemia. Scand J Infect Dis 2008; 40: 44-48.